Hikma Pharmaceuticals (HKMPF) News Today $22.16 -0.26 (-1.16%) As of 10:58 AM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendHeadlinesShort InterestBuy This Stock HKMPF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Hikma Pharmaceuticals (OTCMKTS:HKMPF) Hits New 1-Year Low - Should You Sell?September 14 at 11:47 AM | marketbeat.comHikma Pharmaceuticals (OTCMKTS:HKMPF) Sees Strong Trading Volume - Time to Buy?September 12 at 2:20 PM | marketbeat.comHikma Pharmaceuticals (OTCMKTS:HKMPF) Shares Gap Down - Time to Sell?September 11, 2025 | marketbeat.comHikma Pharmaceuticals slides Friday, underperforms marketAugust 29, 2025 | marketwatch.comHikma Pharmaceuticals (OTCMKTS:HKMPF) Sees Large Volume Increase - Still a Buy?August 27, 2025 | marketbeat.comIf EPS Growth Is Important To You, Hikma Pharmaceuticals (LON:HIK) Presents An OpportunityAugust 26, 2025 | finance.yahoo.comHikma Pharmaceuticals (OTCMKTS:HKMPF) Trading Down 9.2% - Here's WhyAugust 15, 2025 | marketbeat.comHikma Pharmaceuticals (OTCMKTS:HKMPF) Shares Gap Down - Should You Sell?August 12, 2025 | marketbeat.comDIRECTOR DEALINGS: Hikma Pharma vice chair buys after share price fallAugust 11, 2025 | lse.co.ukOne Hikma Pharmaceuticals Insider Raised Stake By 14% In Previous YearAugust 10, 2025 | finance.yahoo.comHikma Pharmaceuticals Executive Vice Chairman Acquires Significant ShareholdingAugust 8, 2025 | tipranks.comHikma Pharmaceuticals tumbles after injectables margin outlook cutAugust 7, 2025 | reuters.comHikma Pharmaceuticals (OTCMKTS:HKMPF) Stock Price Down 0.5% - What's Next?July 24, 2025 | marketbeat.comDrug maker Hikma announces $1 billion Ohio expansion, including its West Side plantJune 30, 2025 | msn.comHikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its ...June 28, 2025 | gurufocus.comHikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its ...June 28, 2025 | gurufocus.comHikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicinesJune 28, 2025 | investing.comOhio EPA fines Hikma Pharmaceuticals in Columbus $4,400 for violating hazardous waste lawsJune 4, 2025 | msn.comHikma Pharmaceuticals Receives Rating Upgrade from FitchMay 29, 2025 | tipranks.comBio-Thera Solutions and Hikma Pharmaceuticals announce FDA approval of STARJEMZA ® (ustekinumab-hmny) Injection, a biosimilar referencing STELARA ® (ustekinumab) InjectionMay 27, 2025 | investing.comAFT Pharmaceuticals Expands US Maxigesic Partnership with HikmaMay 25, 2025 | tipranks.comHikma Pharmaceuticals Executives Involved in Share Pledge TransactionsMay 20, 2025 | tipranks.comHikma Pharmaceuticals Executives Acquire Shares Under DRIPMay 8, 2025 | tipranks.comHikma Pharmaceuticals Announces Managerial Share TransactionsApril 30, 2025 | tipranks.comHikma Pharmaceuticals Successfully Concludes 2025 AGM with All Resolutions PassedApril 24, 2025 | tipranks.comPromising Financial Outlook and Strategic Positioning of Hikma Pharmaceuticals: A Buy Recommendation by Christian GlennieApril 24, 2025 | tipranks.comCould this ‘average’ FTSE 100 stock be one to consider in these difficult times?April 23, 2025 | msn.comHikma Pharmaceuticals USA Inc.: Hikma acquires Novugen's FDA-approved ANDA for trametinibApril 18, 2025 | finanznachrichten.deHikma acquires rights to generic version of Novartis' MekinistApril 17, 2025 | msn.comHikma Pharmaceuticals (HKMPF) Secures U.S. Market Exclusivity for Cancer DrugApril 17, 2025 | gurufocus.comHikma Pharmaceuticals Acquires FDA-Approved ANDA for Trametinib Tablets | HKMPY stock newsApril 17, 2025 | gurufocus.comHikma Pharmaceuticals Announces Discretionary Share Awards to Key ExecutivesApril 10, 2025 | tipranks.comHikma Pharmaceuticals: Strategic Growth and Resilience Amid Market OpportunitiesApril 10, 2025 | tipranks.comHikma Pharmaceuticals Announces Share Disposal by Non-Executive DirectorApril 8, 2025 | tipranks.comHikma Pharmaceuticals slides Monday, underperforms marketMarch 24, 2025 | marketwatch.comHikma Pharmaceuticals rallies Tuesday, outperforms marketMarch 18, 2025 | marketwatch.comAxsome Therapeutics Inc (AXSM) Announces Settlement Agreement with Hikma PharmaceuticalsMarch 5, 2025 | gurufocus.comAxsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Hikma Pharmaceuticals USAMarch 5, 2025 | financialpost.comFHikma Pharmaceuticals Announces Vesting of Executive Share AwardsMarch 4, 2025 | tipranks.comHikma Pharmaceuticals PLC (OTCMKTS:HKMPF) Sees Large Drop in Short InterestMarch 3, 2025 | marketbeat.comHikma Pharmaceuticals PLC (OTCMKTS:HKMPF) Announces Dividend of $0.48February 28, 2025 | marketbeat.comHikma Pharmaceuticals to up R&D spend to support pipeline developmentFebruary 26, 2025 | lse.co.ukHikma Pharmaceuticals (OTCMKTS:HKMPF) Sets New 12-Month High - Here's What HappenedFebruary 25, 2025 | marketbeat.comHikma Pharmaceuticals to Announce 2024 Financial ResultsFebruary 10, 2025 | tipranks.comHikma Pharmaceuticals to release annual results on February 26February 10, 2025 | investing.comHikma Pharmaceuticals (OTCMKTS:HKMPF) Hits New 1-Year High - What's Next?February 7, 2025 | marketbeat.comHikma Pharmaceuticals (OTCMKTS:HKMPF) Hits New 12-Month High - Should You Buy?January 23, 2025 | marketbeat.comHikma Pharmaceuticals Discloses PDMR Share DisposalDecember 23, 2024 | tipranks.comHikma Pharmaceuticals: Strategic Growth and Attractive Valuation Reinforce Buy RatingNovember 8, 2024 | markets.businessinsider.comHikma Pharmaceuticals remains steady Tuesday, underperforms marketOctober 1, 2024 | marketwatch.com Get Hikma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for HKMPF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HKMPF Media Mentions By Week HKMPF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HKMPF News Sentiment▼0.470.94▲Average Medical News Sentiment HKMPF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HKMPF Articles This Week▼31▲HKMPF Articles Average Week Get the Latest News and Ratings for HKMPF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Hikma Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Summit Therapeutics News United Therapeutics News Merck KGaA News Shionogi & Co., Ltd. Unsponsored ADR News Neurocrine Biosciences News Recordati Industria Chimica E Farmaceutica News IPSEN News Orion OYJ News Ionis Pharmaceuticals News Madrigal Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:HKMPF) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hikma Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hikma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
